RANOLAZINE ER 500 MG TABLET

Ranolazine
$0.1624per EA
Low Outlier

Strength

500 mg/1

NDC

63304001760

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

2/18/2026

Active Ingredients

RANOLAZINE

Approval Type

Generic (ANDA)

FDA Application

ANDA211707

On Market Since

5/28/2019

Pharmacological Classes

Anti-anginal
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
Organic Cation Transporter 2 Inhibitors
P-Glycoprotein Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

-0.3%

6M

-1.7%

1Y

-21.3%

3Y

-24.5%

5Y

-54.9%

All

-75.2%